TD Cowen Initiates Coverage On Odyssey Therapeutics with Buy Rating

Benzinga Newsdesk www.benzinga.com Neutral 66.4%

Neg 0% Neu 66.4% Pos 0%

TD Cowen analyst Tyler Van Buren initiates coverage on Odyssey Therapeutics (NASDAQ:ODTX) with a Buy rating.

Comments

No comments yet. Be the first!